Syros Pharmaceuticals Inc. diskutieren
Syros Pharmaceuticals Inc.
WKN: A3DT8V / Symbol: SYRS / Name: Syros Pharmaceuticals / Aktie / Pharmazeutika / Small Cap /
0,10 €
-14,66 %
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $13.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its price target lowered by analysts at HC Wainwright from $15.00 to $6.00. They now have a "buy" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $5.00 price target on the stock, down previously from $13.00.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Syros Pharmaceuticals, Inc. (NASDAQ: SYRS) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for SYRS provided by MarketBeat
Neueste Beiträge
TD_Securities in Bank of Montreal diskutieren